Alembic Pharmaceuticals Limited recalls Doxepin Hydrochloride Capsules
- Published
- 13 Aug 2025
- Units affected
- 9,492 bottles
- Agency
- FDA
- Country
- United States
The hazard
CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Doxepin Hydrochloride Capsules, USP, 10 mg, 100 Capsules, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panela v 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-637-31
- Brand / company
- Alembic Pharmaceuticals Limited
- Codes / lots
- Lot: 2305015142, Exp. Date: 9/30/2025
- Distribution
- Nationwide in the USA.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 13 Aug 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.